ReviewHematological oncology2018

Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms.

Tariq I Mughal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.